Literature DB >> 11091222

Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.

H Tamary1, R Bar-Yam, L Shalmon, G Rachavi, M Krostichevsky, R Elhasid, Y Barak, J Kapelushnik, I Yaniv, A D Auerbach, R Zaizov.   

Abstract

Fanconi anaemia (FA) is a genetically heterogeneous disease with at least eight complementation groups (A-H). In the present study, we investigated the molecular basis of the disease in 13 unrelated Israeli Jewish (non-Ashkenazi) patients with FA. All 43 exons of the Fanconi anaemia A (FANCA) gene were amplified from genomic DNA and screened for mutations by single-strand conformation polymorphism and DNA sequencing. We identified four ethnic-specific mutations: (1) 2172-2173insG (exon 24), the first 'Moroccan mutation': (2) 4275delT (exon 43), the second 'Moroccan mutation'; (3) 890-893del (exon 10), the 'Tunisian mutation'; and (4) 2574C > G (S858R), the 'Indian mutation'. The tetranucleotide CCTG motif, previously identified as a mutation hotspot in FANCA and other human genes, was found in the vicinity of 2172-2173insG and 890-893del. According to our study, the four mutations account for the majority (88%) of the FANCA alleles in the Israeli Jewish (non-Ashkenazi) FA population. A screening of 300 Moroccan Jews identified three carriers of the first 'Moroccan mutation', but we did not find any carrier of the second 'Moroccan mutation' among 140 Moroccan Jews, nor any carrier of the 'Tunisian mutation' among 50 Tunisian Jews. Two 'Indian mutation' carriers were identified among 53 Indian Jews. All carriers within each ethnic group had the same haplotype, suggesting a common founder for each mutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091222     DOI: 10.1046/j.1365-2141.2000.02323.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results.

Authors:  Susan Harlap; A Michael Davies; Lisa Deutsch; Ronit Calderon-Margalit; Orly Manor; Ora Paltiel; Efrat Tiram; Rivka Yanetz; Mary C Perrin; Mary B Terry; Dolores Malaspina; Yechiel Friedlander
Journal:  Paediatr Perinat Epidemiol       Date:  2007-05       Impact factor: 3.980

Review 3.  Clinical radiation sensitivity with DNA repair disorders: an overview.

Authors:  Julianne M Pollard; Richard A Gatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

4.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

Review 5.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

6.  Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Authors:  Nadhir Litim; Yvan Labrie; Sylvie Desjardins; Geneviève Ouellette; Karine Plourde; Pascal Belleau; Francine Durocher
Journal:  Mol Oncol       Date:  2012-09-11       Impact factor: 6.603

Review 7.  The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility.

Authors:  Inbal Kedar-Barnes; Paul Rozen
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Authors:  Chiraz Bouchlaka; Sonia Abdelhak; Ahlem Amouri; Hela Ben Abid; Sondes Hadiji; Mounir Frikha; Tarek Ben Othman; Fethi Amri; Hammadi Ayadi; Mongia Hachicha; Ahmed Rebaï; Ali Saad; Koussay Dellagi
Journal:  J Hum Genet       Date:  2003-06-24       Impact factor: 3.172

9.  Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.

Authors:  Daniela De Rocco; Roberta Bottega; Enrico Cappelli; Simona Cavani; Maria Criscuolo; Elena Nicchia; Fabio Corsolini; Chiara Greco; Adriana Borriello; Johanna Svahn; Marta Pillon; Cristina Mecucci; Gabriella Casazza; Federico Verzegnassi; Chiara Cugno; Anna Locasciulli; Piero Farruggia; Daniela Longoni; Ugo Ramenghi; Walter Barberi; Fabio Tucci; Silverio Perrotta; Paola Grammatico; Helmut Hanenberg; Fulvio Della Ragione; Carlo Dufour; Anna Savoia
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

10.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.